Abstract:Metal ions can perform multiple roles ranging from regulatory to structural and are crucial for cell function. While some metal ions like Na + are ubiquitously present at high concentrations, other ions, especially Ca 2+ and transition metals, such as Zn 2+ or Cu +/2+ are regulated. The concentrations above or below the physiological range cause severe changes in the behavior of biomolecules that bind them and subsequently affect the cell wellbeing. This has led to the development of specialized protocols to study metal ion binding biomolecules in bulk conditions that mimic the cell environment. Recently, there is growing evidence of influence of post-transcriptional and post-translational modifications on the affinity of the metal ion binding sites. However, such targets are difficult to obtain in amounts required for classical biophysical experiments. Single molecule techniques have revolutionized the field of biophysics, molecular and structural biology. Their biggest advantage is the ability to observe each molecule's interaction independently, without the need for synchronization. An additional benefit is its extremely low sample consumption. This feature allows characterization of designer biomolecules or targets obtained coming from natural sources. All types of biomolecules, including proteins, DNA and RNA were characterized using single molecule methods. However, one group is underrepresented in those studies. These are the metal ion binding biomolecules. Single molecule experiments often require separate optimization, due to extremely different concentrations used during the experiments. In this review we focus on single molecule methods, such as single molecule FRET, nanopores and optical tweezers that are used to study metal ion binding biomolecules. We summarize various examples of recently characterized targets and reported experimental conditions. Finally, we discuss the potential promises and pitfalls of single molecule characterization on metal ion binding biomolecules.

On the hunt for metalloenzyme inhibitors: Investigating the Presence of Metal-Chelating Compounds in Screening Libraries and Chemical Spaces

On the hunt for metalloenzyme inhibitors: Investigating the presence of metal‐coordinating compounds in screening libraries and chemical spaces

Structural Approaches to Probing Metal Interaction with Proteins

Targeting Metalloenzymes by Boron-Containing Metal-Binding Pharmacophores

Ligand and structure-based discovery of phosphorus-containing compounds as potential metalloproteinase inhibitors

Unlocking Precision Docking for Metalloproteins

Inferring metal binding sites in flexible regions of proteins

Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors

Structure-Based Virtual Screening of Chemical Libraries for Drug Discovery

Discovery of Novel Metalloenzyme Inhibitors Based on Property Characterization: Strategy and Application for HDAC1 Inhibitors

Biological Activity of Late Transition Metal‐Based Compounds: From Computational and Theoretical Studies to Laboratory Exploration and Beyond

Identification of promising methionine aminopeptidase enzyme inhibitors: A combine study of comprehensive virtual screening and dynamics simulation study

BioBrigit, A Hybrid Deep Learning and Knowledge-based Approach to Model Metal Pathways in Proteins: Application to a Di-Copper Tyrosinase

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

Metalloenzyme design and engineering through strategic modifications of native protein scaffolds

High-throughput screening and Bayesian machine learning for copper-dependent inhibitors of Staphylococcus aureus

Investigation of metal ion binding biomolecules one molecule at a time

A Mechanism to Open Academic Chemistry to High-Throughput Virtual Screening

Efficient Exploration of Chemical Space with Docking and Deep Learning

Computational Discovery of Transition-metal Complexes: From High-throughput Screening to Machine Learning

Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: Structure-based virtual screening, ADMET prediction and molecular dynamics studies